+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Anticancer Agent"

Chemotherapy-induced Diarrhea Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Chemotherapy-induced Diarrhea Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Antibody Drug Conjugates Pipeline Analysis Report 2025 - Product Thumbnail Image

Antibody Drug Conjugates Pipeline Analysis Report 2025

  • Report
  • June 2025
  • 200 Pages
  • Global
From
Neuroendocrine Tumors Market - Product Thumbnail Image

Neuroendocrine Tumors Market

  • Report
  • January 2025
  • 250 Pages
  • Global
From
Innovation Insights: Antibody-drug conjugates - Product Thumbnail Image

Innovation Insights: Antibody-drug conjugates

  • Report
  • January 2025
  • 54 Pages
  • Global
From
ADC Technology Market: Focus on ADC Linker and ADC Conjugation Technologies (2nd Edition) - Distribution by Generation of ADC Technology, Type of Conjugation, Type of Linker and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035 - Product Thumbnail Image

ADC Technology Market: Focus on ADC Linker and ADC Conjugation Technologies (2nd Edition) - Distribution by Generation of ADC Technology, Type of Conjugation, Type of Linker and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035

  • Report
  • July 2023
  • 407 Pages
  • Global
From
Cytotoxic Drugs and HPAPI Manufacturing Market by Type of Product, Company Size, Scale of Operation, Type of Molecule, Type of Highly Potent Finished Dosage Form, and Key Geographies, Europe, Asia-Pacific and Rest of the World: Industry Trends and Global Forecasts, 2022-2035 - Product Thumbnail Image

Cytotoxic Drugs and HPAPI Manufacturing Market by Type of Product, Company Size, Scale of Operation, Type of Molecule, Type of Highly Potent Finished Dosage Form, and Key Geographies, Europe, Asia-Pacific and Rest of the World: Industry Trends and Global Forecasts, 2022-2035

  • Report
  • October 2022
  • 338 Pages
  • Europe, Global, Asia Pacific Europe, Global, Asia Pacific
From
Novel Antibody Therapies Market: Distribution by Type of Novel Antibody, Target Indication, Type of Therapy, Route of Administration, and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035 - Product Thumbnail Image

Novel Antibody Therapies Market: Distribution by Type of Novel Antibody, Target Indication, Type of Therapy, Route of Administration, and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035

  • Report
  • August 2022
  • 214 Pages
  • Global
From
HPAPI and Cytotoxic Drugs Manufacturing Market (3rd Edition), 2020-2030 - Product Thumbnail Image

HPAPI and Cytotoxic Drugs Manufacturing Market (3rd Edition), 2020-2030

  • Report
  • February 2020
  • 304 Pages
  • Global
From
Lyophilisation in Pharmaceutical Market Report 2023-2033 - Product Thumbnail Image

Lyophilisation in Pharmaceutical Market Report 2023-2033

  • Report
  • November 2022
  • 260 Pages
  • Global
From
PSMA - Targeted Therapy Pipeline Review - Product Thumbnail Image

PSMA - Targeted Therapy Pipeline Review

  • Report
  • July 2025
  • Global
From
Targeted Oncology Therapeutics: Hematology Cancers - Product Thumbnail Image

Targeted Oncology Therapeutics: Hematology Cancers

  • Report
  • October 2021
  • 110 Pages
  • Global
From
Global Bicycle Toxin Conjugates Clinical Trials & Market Opportunity Insight 2024 - Product Thumbnail Image

Global Bicycle Toxin Conjugates Clinical Trials & Market Opportunity Insight 2024

  • Report
  • February 2024
  • 50 Pages
  • Global
From
Japan Cancer Drug Market, Dosage, Price & Clinical Trials Insight 2025 - Product Thumbnail Image

Japan Cancer Drug Market, Dosage, Price & Clinical Trials Insight 2025

  • Report
  • July 2020
  • 1200 Pages
  • Japan
From
Global Cancer Tubulin Inhibitors Market & Clinical Trial Insight 2024 - Product Thumbnail Image

Global Cancer Tubulin Inhibitors Market & Clinical Trial Insight 2024

  • Clinical Trials
  • February 2018
  • 225 Pages
  • Global
From
Global Cancer mTOR Inhibitors Market & Clinical Pipeline Outlook 2022 - Product Thumbnail Image

Global Cancer mTOR Inhibitors Market & Clinical Pipeline Outlook 2022

  • Report
  • February 2018
  • 160 Pages
  • Global
From
Injectable Cytotoxic Drugs Market: Market Size, Trends, Opportunities and Forecast By Drug Class, Application, Distribution Channel, Region, By Country: 2020-2030 - Product Thumbnail Image

Injectable Cytotoxic Drugs Market: Market Size, Trends, Opportunities and Forecast By Drug Class, Application, Distribution Channel, Region, By Country: 2020-2030

  • Report
  • June 2024
  • 310 Pages
  • Global
From
Research Report on China's Anlotinib Hydrochloride Market, 2021-2025 - Product Thumbnail Image

Research Report on China's Anlotinib Hydrochloride Market, 2021-2025

  • Report
  • November 2021
  • 40 Pages
  • China
From
Research Report on China's Lobaplatin Market, 2021-2025 - Product Thumbnail Image

Research Report on China's Lobaplatin Market, 2021-2025

  • Report
  • September 2021
  • 40 Pages
  • China
From
Investigation Report on China's Osimertinib Market 2021-2025 - Product Thumbnail Image

Investigation Report on China's Osimertinib Market 2021-2025

  • Report
  • April 2021
  • China
From
Minimal Residual Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Minimal Residual Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 138 Pages
  • Global
From
Loading Indicator

The Anticancer Agent market is a segment of the Healthcare Services industry that focuses on the development and distribution of drugs and treatments for cancer. These agents are designed to target and destroy cancer cells while minimizing the damage to healthy cells. They can be administered orally, intravenously, or topically, depending on the type of cancer and the patient's individual needs. Anticancer agents are used in combination with other treatments such as radiation and chemotherapy to provide the best possible outcome for the patient. The Anticancer Agent market is highly competitive, with many companies vying for market share. Companies in this market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more